MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0079077
Curis Pharma Private Limited
Curis Pharma Private Limited - chemicals in Lucknow, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹33.14 Lakh
▲ 37% YoY
Net loss · FY 2025
₹23,970
Net margin -0.7%
EBITDA · FY 2025
-₹22,806
EBITDA margin -0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Curis Pharma Private Limited
Data last updated:
Curis Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 25 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2019PTC119472. Its GSTIN is 09AAICC2978G1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anupam Kumar Pandey and Bharti Pandey.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 3 Madhupuram Coloney Bhithauli Khurd Stp Rd, Lucknow, Uttar Pradesh, India – 226020.
As per the financials filed for FY 2025, the company reported a revenue of ₹33.14 Lakh, a growth of 37% compared to the previous year. For the same year it recorded a net loss of ₹23,970 (net margin -0.7%) and EBITDA of -₹22,806 (EBITDA margin -0.7%). Revenue has grown at a compounded annual rate (CAGR) of 262% over three years.
Curis Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0079077).
Company details
CIN U24299UP2019PTC119472
Registration Number 119472
Incorporation Date 25 July 2019
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0079077
Recognitions & Rankings of Curis Pharma
Contact details
Curis Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 3 Madhupuram Coloney Bhithauli Khurd Stp Rd, Lucknow, Uttar Pradesh, India – 226020
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Curis Pharma Private Limited, buy the company report.
Comprehensive company report
Curis Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Curis Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curis Pharma Private Limited, buy the company report.
Financials of Curis Pharma Private Limited
FY 2025 filings availableCuris Pharma Private Limited reported revenue of ₹33.14 Lakh (up 37% YoY) for FY 2025.
Revenue · FY 2025
₹33.14 Lakh ▲ 37%
Net loss · FY 2025
₹23,970 margin -0.7%
EBITDA · FY 2025
-₹22,806 margin -0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 37%
3 years · compounded
▲ 262%
EBITDA CAGR growth
1 year
▼ 20%
3 years · compounded
▲ 51%
5 years · compounded
▲ 4%
Revenue has grown at a compounded annual rate (CAGR) of 262% over three years, including 37% growth in the latest year. EBITDA fell 20% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹22,806 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹23,970 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.7% | ||||
| Net Profit Margin | -0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Curis Pharma Private Limited, buy the company report.
Board of directors of Curis Pharma Private Limited
Curis Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anupam Kumar Pandey Also directs: Nosam Labs Private Limited | Director | 25 Jul 2019 | 7 Years 2 Months | Current |
| Bharti Pandey | Additional Director | 23 Dec 2020 | 5 Years 9 Months | Current |
Peer comparison
Curis Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ojaskara Medicament Private Limited | ₹33.17 Lakh (FY 2024) | 51.0% | Rairangpur, Odisha, India | |||
| Sterling Star Beverages Private Limited | ₹33.15 Lakh (FY 2025) | -62.0% | Kolkata, West Bengal, India | |||
| Trinetra Dairy Products Private Limited | ₹33.15 Lakh (FY 2025) | 26.0% | Hyderabad, Telangana, India | |||
| Prakash Renewable Solutions India Private Limited | ₹33.15 Lakh (FY 2024) | -12.0% | New Delhi, Delhi, India | |||
| V S Electricals Private Limited | ₹33.15 Lakh (FY 2025) | -80.0% | Kolkata, West Bengal, India | |||
| Curis Pharma Private Limitedthis company | ₹33.14 Lakh (FY 2025) | -₹23,970 | -0.7% | 37.0% | Lucknow, Uttar Pradesh, India | |
| Belhaven Impex Private Limited | ₹33.14 Lakh (FY 2025) | -52.0% | Thiruvananthapuram, Kerala, India | |||
| Shree Shyam Tradehouse Private Limited | ₹33.14 Lakh (FY 2025) | 0.0% | Bhilwara, Rajasthan, India | |||
| Avighna Vinimay Private Limited. | ₹33.14 Lakh (FY 2025) | 37.0% | Kolkata, West Bengal, India | |||
| Chamkaur Sahib Producer Company Limited | ₹33.14 Lakh (FY 2025) | 14.0% | Chamkaur Sahib, Punjab, India | |||
| Boomtech Solutions Private Limited | ₹33.14 Lakh (FY 2023) | 6818563.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Curis Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curis Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curis Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curis Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICC2978G1ZB | Uttar Pradesh | Active | 03 Aug 2019 |
To see the full GST registrations and return filing status of Curis Pharma Private Limited, buy the company report.
Recent activity
Curis Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Bharti Pandey was appointed as Additional Director on 23 Dec 2020.
AGM
Curis Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Curis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Appointed
Bharti Pandey was appointed as Additional Director.
Ceased
Rekha Pandey ceased to be Director.
Appointed
Anupam Kumar Pandey was appointed as Director.
Incorporation
25 Jul 2019
Curis Pharma Private Limited was registered on 25 Jul 2019 with Roc Uttar Pradesh I & aged 7 years 2 months as per MCA records.
Frequently asked questions
Curis Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 25 July 2019 (7+ years old) and is registered under CIN U24299UP2019PTC119472.
Curis Pharma has 2 current directors:
- Anupam Kumar Pandey - Director
- Bharti Pandey - Additional Director
The latest financial statements of Curis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Curis Pharma is 09AAICC2978G1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Curis Pharma is U24299UP2019PTC119472. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curis Pharma was incorporated on 25 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Curis Pharma by revenue are Ojaskara Medicament Private Limited, Sterling Star Beverages Private Limited, Trinetra Dairy Products Private Limited, Prakash Renewable Solutions India Private Limited, V S Electricals Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Bharti Pandey was appointed as Additional Director on 23 Dec 2020. Rekha Pandey ceased to be Director on 07 Sep 2020. Anupam Kumar Pandey was appointed as Director on 25 Jul 2019.
Yes, Curis Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0079077).
The registered office of Curis Pharma is at Plot No. 3 Madhupuram Coloney Bhithauli Khurd Stp Rd, Lucknow, Uttar Pradesh, India – 226020.
Curis Pharma operates in the chemicals industry, in the fine chemicals and other chemical products segment.